Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Artificial Insemination Market: By Product Type, By Procedure Type, By End User, and Region Forecast 2020-2031
Artificial Insemination Market: By Product Type, By Procedure Type, By End User, and Region Forecast 2020-2031
Artificial Insemination Market size was valued at US$ 2.5 billion in 2024 and is expected to reach US$ 4.5 billion by 2031, growing at a significant CAGR of 8.8% from 2025-2031. To cure infertility, a procedure known as artificial insemination involves placing semen directly into a woman's womb. This treatment aims to directly inject cleaned sperm into the uterus, cervix, or fallopian tubes using a thin, flexible foley catheter that is inserted through the cervix. This can then lead to pregnancies in women who were previously unable to get pregnant for various reasons. Intrauterine insemination is another name for this procedure in medicine. Due to the increased incidence of infertility problems in both males and females, broad technology breakthroughs in the medical field, and rising healthcare costs across the globe, this market vertical is experiencing profitable growth.
Animal breeders now frequently employ artificial insemination to increase reproductive success and protect endangered species. Additionally, it stops the spread of some illnesses and the sterility caused by genital disorders in animals. For example, Beijing Capital Agribusiness Co. Ltd., a prominent Chinese animal protein genetics company, and Genus's plc., a leading animal genetics company, worked together to study and create virus-resistant methods in pigs. Major pharmaceutical companies are driving market expansion with their rapid development of drugs during preclinical and clinical testing, as well as with the launch of novel insemination kits that have demonstrated prospective benefits.
Study Period
2025-2031Base Year
2024CAGR
8.8%Largest Market
North-AmericaFastest Growing Market
Europe
Increase in the prevalence of infertility among the men and women is a major factor surge the growth of artificial insemination market over the forecast years. Increase in the prevalence of infectious diseases, genetic issues, and unhealthy lifestyle are the major factors enhance the infertility among the population. For instance, according to National Survey of Family Growth approximately 15.5% of female population intended to become pregnant are infertile. In addition, as per Center for Disease Control and Prevention, approximately 6.1 Mn female aged between 15-44 years are infertile in USA. Furthermore, development of advanced insemination kits by the market players also surge the market over the forecast timeframe.
Global artificial insemination market report gives comprehensive outlook on artificial insemination across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America expected to dominate the market by 2025 owing to increase in the prevalence of infertile prevalence in USA and Canada, increase in the adoption of technological advanced procedures, sophisticated healthcare infrastructure, and favorable reimbursement policies present in the region. Moreover, Europe market contributed highest growth rate in 2019 and expected to grow at 5.6% CAGR over the forecast years owing to increase in research and development on newer procedures, unhealthy lifestyle, and adoption of advanced technologies in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 2.5 billion |
|
Market Size in 2031 |
US$ 4.5 billion |
|
Market CAGR |
8.8% |
|
By Product Type |
|
|
By Procedure Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The artificial insemination market size was valued at US$ 2.5 billion in 2024 and is expected to reach US$ 4.5 billion by 2031, growing at a significant CAGR of 8.8% from 2025-2031.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The market key players Vitrolife, Genea Limited, Kitazato Corporation, Bescot Healthcare, Church & Dwight Co., Inc, Kate & Duck Insemination Supplies, LLC, Zander scientific Inc, Conceivex, Inc., TenderNeeds, Fertility Biogenics Inc, Hamilton Throne Ltd., Rinovum Womens Health LLC, Pride Angel Nikon Instruments Inc, Worthington Industries
| 1.Executive Summary |
| 2.Global Artificial Insemination Market Introduction |
| 2.1.Global Artificial Insemination Market - Taxonomy |
| 2.2.Global Artificial Insemination Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Procedure Type |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Artificial Insemination Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Artificial Insemination Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Artificial Insemination Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Insemination Kits |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Home Conception Devices |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Accessories |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Artificial Insemination Market By Procedure Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Intravaginal Insemination |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Intracervical Insemination |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Intrauterine Insemination |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Intratubal Insemination |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Artificial Insemination Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals and Clinics |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Fertility Centers |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Artificial Insemination Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Artificial Insemination Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Insemination Kits |
| 9.1.2.Home Conception Devices |
| 9.1.3.Accessories |
| 9.2. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Intravaginal Insemination |
| 9.2.2.Intracervical Insemination |
| 9.2.3.Intrauterine Insemination |
| 9.2.4.Intratubal Insemination |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals and Clinics |
| 9.3.2.Fertility Centers |
| 9.3.3.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Artificial Insemination Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Insemination Kits |
| 10.1.2.Home Conception Devices |
| 10.1.3.Accessories |
| 10.2. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Intravaginal Insemination |
| 10.2.2.Intracervical Insemination |
| 10.2.3.Intrauterine Insemination |
| 10.2.4.Intratubal Insemination |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals and Clinics |
| 10.3.2.Fertility Centers |
| 10.3.3.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Artificial Insemination Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Insemination Kits |
| 11.1.2.Home Conception Devices |
| 11.1.3.Accessories |
| 11.2. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Intravaginal Insemination |
| 11.2.2.Intracervical Insemination |
| 11.2.3.Intrauterine Insemination |
| 11.2.4.Intratubal Insemination |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals and Clinics |
| 11.3.2.Fertility Centers |
| 11.3.3.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Artificial Insemination Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Insemination Kits |
| 12.1.2.Home Conception Devices |
| 12.1.3.Accessories |
| 12.2. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Intravaginal Insemination |
| 12.2.2.Intracervical Insemination |
| 12.2.3.Intrauterine Insemination |
| 12.2.4.Intratubal Insemination |
| 12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals and Clinics |
| 12.3.2.Fertility Centers |
| 12.3.3.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Artificial Insemination Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Insemination Kits |
| 13.1.2.Home Conception Devices |
| 13.1.3.Accessories |
| 13.2. Procedure Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Intravaginal Insemination |
| 13.2.2.Intracervical Insemination |
| 13.2.3.Intrauterine Insemination |
| 13.2.4.Intratubal Insemination |
| 13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals and Clinics |
| 13.3.2.Fertility Centers |
| 13.3.3.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Vitrolife |
| 14.2.2.Genea Limited |
| 14.2.3.Kitazato Corporation |
| 14.2.4.Bescot Healthcare |
| 14.2.5.Church & Dwight Co., Inc. |
| 14.2.6.Kate & Duck |
| 14.2.7.Insemination Supplies, LLC |
| 14.2.8.Zander scientific Inc. |
| 14.2.9.Conceivex, Inc. |
| 14.2.10.TenderNeeds Fertility |
| 14.2.11.Biogenics Inc. |
| 14.2.12.Hamilton Throne Ltd. |
| 14.2.13.Rinovum Womens Health, LLC |
| 14.2.14.Pride Angel |
| 14.2.15.Nikon Instruments Inc. |
| 14.2.16.Worthington Industries |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.